BMRN vs GANX · P/E 40, rev $1.76B vs $53.0M cap
Biomarin Pharmaceutical Inc (BMRN) versus Gain Therapeutics Inc (GANX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
GANX does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GANX currently screens at market cap $53.0M.
Not investment advice. Open the BMRN and GANX stock pages for the full models.
Not investment advice.